BOTHELL, Wash.--(BUSINESS WIRE)--Helix BioMedix, Inc., (OTCBB: HXBM), a developer of bioactive peptides, today announced that R. Stephen Beatty, President and Chief Executive Officer, will present at the Friedland Life Science Forum at the Palm Too Restaurant in New York, New York. Mr. Beatty is scheduled to present on Thursday, June 12 at 12:30 in the afternoon.
